Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1611160 | 1.00 | HTT (0.44) | HTTCYP2A6L3MBTL1TSHRMCHR1 | |
| SCHEMBL1610243 | 0.98 | CYP2A6 (0.44) | HTTCYP2A6L3MBTL1TSHRMCHR1 | |
| SCHEMBL1612718 | 0.91 | CYP2A6 (0.46) | HTTCYP2A6L3MBTL1TSHRMCHR1 | |
| SCHEMBL1611178 | 0.82 | CYP2A6 (0.50) | CYP2A6L3MBTL1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL6320373 | 0.82 | ALDH1A1 (0.39) | TSHRNPC1RAB9ASMN1; SMN2KCNH2 | |
| SCHEMBL2323474 | 0.82 | ALDH1A1 (0.52) | — | |
| SCHEMBL11146710 | 0.82 | KCNH2 (0.47) | L3MBTL1SMN1; SMN2KCNH2 | |
| SCHEMBL1611201 | 0.82 | ALDH1A1 (0.43) | TSHRSMN1; SMN2TNNC1 | |
| SCHEMBL1610247 | 0.82 | ALDH1A1 (0.43) | TSHRSMN1; SMN2TNNC1 | |
| SCHEMBL304116 | 0.81 | TDP1 (0.47) | TSHRSMN1; SMN2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | HTT 774/4885CYP2A6 1465/4885L3MBTL1 236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.